Seongnam, South Korea

Ki Teak Lee

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Ami Pharm Co., Ltd.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ki Teak Lee. Retrieved from https://idiyas.com/inventor/ki-teak-lee-992h8gkt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ki Teak Lee: Innovator in Lipolysis Composition

Introduction

Ki Teak Lee is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of medical compositions, particularly in the area of lipolysis. His innovative work focuses on developing compositions that can effectively induce lipolysis while minimizing adverse side effects.

Latest Patents

Ki Teak Lee holds 1 patent for his invention titled "Composition for lipolysis, containing phosphatidylcholine, and preparation method therefor." This composition includes phosphatidylcholine, an oily solvent, and water, designed to induce lipolysis without causing side effects such as edema, erythema, tissue necrosis, and inflammation. The formulation may consist of 2-12% (w/v) of phosphatidylcholine and 5-12% (w/v) of an oily solvent, balanced with water.

Career Highlights

Ki Teak Lee is associated with Ami Pharm Co., Ltd., where he continues to work on innovative solutions in the pharmaceutical field. His expertise in developing effective compositions has positioned him as a valuable asset in the industry.

Collaborations

(Section skipped due to space constraints.)

Conclusion

Ki Teak Lee's contributions to the field of lipolysis compositions highlight his innovative spirit and dedication to advancing medical science. His work not only addresses the need for effective treatments but also emphasizes safety and efficacy in pharmaceutical formulations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…